Science AI Journal
Medicine · Research topic

Open research questions in Botulinum Toxin and Related Neurological Disorders

98 gap statements mined from Botulinum Toxin and Related Neurological Disorders papers in our 4.5M-paper local library, which holds 713 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Botulinum Toxin and Related Neurological Disorders? See the ranked Medicine journals.

What the literature leaves open

  • The traditional explanation of sensory tricks as being due to peripheral sensory input is insufficient. There is a lack of understanding of the role of higher-level cognitive and attentional processes in shaping motor control in dystonia.

    Attentional or Non-Tactile Sensory Tricks in Idiopathic Cervical Dystonia: A Phenomenological Observation · 2026 · DOI

  • The process by which patients identified these non-tactile tricks was not systematically assessed, representing a limitation and an area for future investigation. Controlled neurophysiological recording at the time of non-tactile tricks would be used to further define their neural substrates and help characterize cortical circuitry mediating this effect.

    Attentional or Non-Tactile Sensory Tricks in Idiopathic Cervical Dystonia: A Phenomenological Observation · 2026 · DOI

  • The need to understand how toxin-receptor binding and other factors determine clinical effect. The need to optimize reconstitution volume and injection technique to improve toxin distribution and clinical outcomes.

    Neuromodulators for Facial Aesthetics: Mechanistic Postulates and Clinical Implications · 2026 · DOI

  • There is a need to understand how toxin-receptor binding and other factors determine clinical effect.

    Neuromodulators for Facial Aesthetics: Mechanistic Postulates and Clinical Implications · 2026 · DOI

  • The study's findings are limited by methodological limitations, particularly in regions with low-intensity signals. The interpretation of the results requires caution, considering the potential for indirect central pathways within hypothalamic circuits.

    Regional Brain Localization of Botulinum Toxin Type A-Truncated Synaptosomal-Associated Protein 25 After Injection into the Rat Hind Paw · 2026 · DOI

  • There is a need for further research on the long-term effects of botulinum toxin treatment. There is a need for more studies on the use of botulinum toxin in treating various strabology and neurology conditions.

    The role of botulinum toxin in the treatment of patients in strabology and neurology outpatient clinics · 2026 · DOI

  • The large progenitor toxin complex (L-PTC) crosses the intestinal epithelial barrier to deliver BoNT to target neurons; however, it is not clearly understood how BoNT enters the host.

    LRP1 is an entry receptor for the botulinum toxin complex in the gut · 2026 · DOI

  • The critical question this review addresses, is whether these established symptomatic benefits translate into meaningful reductions in AP risk, and the answer, based on current evidence, remains uncertain.

    Botulinum toxin A for sialorrhea in adults with neurological disorders: a narrative review of aspiration pneumonia risk · 2026 · DOI

  • There is a lack of knowledge regarding the long-term outcomes of repeated cosmetic botulinum toxin injections. There is a need to monitor subjective and objective neurological symptoms after invasive cosmetic procedures.

    АDVERSE EFFECTS AND NEUROLOGICAL DISORDERS AFTER INVASIVE COSMETOLOGY · 2026 · DOI

  • Despite extensive research, the underlying aetiology remains unknown in a significant percentage of patients (primary or idiopathic tinnitus).

    Masseter Muscle in Somatosensory Tinnitus and Potential Therapeutic Role for Botulinum Toxin Type A: A Scoping Review · 2026 · DOI

  • These limitations highlight that future research should focus on evaluating current evidence-based treatments for TMD, MMH, MH, and bruxism, as well as the correlation with somatosensory tinnitus.

    Masseter Muscle in Somatosensory Tinnitus and Potential Therapeutic Role for Botulinum Toxin Type A: A Scoping Review · 2026 · DOI

  • There is a lack of high-quality evidence on the efficacy and safety of botulinum toxin for bruxism and myofascial pain. The optimal dose and number of sessions are not well established.

    Toxina Botulínica para Bruxismo e Dor Miofascial · 2026 · DOI

  • The study identifies that the complexity of resistance to botulinum toxin type A is based on multiple factors including molecular structure of products, application techniques, and individual patient characteristics. It emphasizes the need for personalized therapeutic approaches and knowledge about switching between brands to maximize efficacy and safety.

    RESISTÊNCIA À TOXINA BOTULÍNICA TIPO A: COMPARAÇÃO ENTRE TRÊS MARCAS NA ESTÉTICA · 2026 · DOI

  • There is limited controlled evidence on the use of dry needling in children with cerebral palsy. The study aims to address the gap in the literature by investigating the efficacy of dry needling in reducing spasticity and improving functional outcomes in children with spastic cerebral palsy.

    Adjunctive dry needling reduces spasticity and improves functional outcomes in children with cerebral palsy: a single-blind randomized controlled trial · 2026 · DOI

  • There is a need for proportionate safety guidance for SLS due to the risk of visually triggered seizures. Prior work has not addressed the safety of SLS in various settings.

    Stroboscopic Light Stimulation Safety Within and Beyond Laboratory Settings: Observational Evidence and Practical Guidance · 2026 · DOI

  • Immediate-injection evidence and patient-reported outcomes remain uncertain, and cross-study dose escalation within 4–10 U/cm was not associated with additional benefit.

    Botulinum Toxin Type A for Postoperative Scar Prevention: A Systematic Review and Meta-analysis · 2026 · DOI

  • By identifying a pattern of social cognition deficit in IFD patients, this study advances understanding of its non-motor symptoms and underscores the need for further research on its impact on daily functioning and quality of life.

    Social cognition in idiopathic focal dystonia: preliminary evidence on its relationship with cognitive and affective-behavioral functioning · 2026 · DOI

  • The paper highlights the need for a comprehensive understanding of post-stroke spasticity and its treatment options as a challenge.

    Post-stroke spasticity: advances in network mechanisms and therapeutics · 2026 · DOI

  • Likewise, while P-80 demonstrates promise as a permeationenhancing carrier molecule, its broader applicability as a universal carrier for nanoparticle- or protein-based therapeutics remains to be determined.

    BoNT/E-associated protein disrupts intestinal epithelial barrier integrity to facilitate transcytosis · 2026 · DOI

  • Such generalization may compromise treatment decisions and outcomes and is compounded by using manual tools like the Tardieu and modified Tardieu Scales, which lack evidence of validity and reliability, and the Ashworth and modified Ashworth Scales, which do not measure the velocity-dependent nature of spasticity or provide dependable insights into the mechanisms driving the torque changes.

    Is Spasticity a Syndrome? A Historical Perspective on Spasticity Definitions and Descriptions · 2026 · DOI

  • Traditional management involves anticholinergic drugs and clean intermittent catheterization, but these have significant side effects. Surgical procedures like augmentation cystoplasty are associated with high risks of severe complications.

    Experience with Intravesical Botox in Meningomyelocele-Related Bladder Dysfunction-A Single-Center Experience · 2026 · DOI

  • The study had a small sample size of 10 patients. The follow-up period was limited to 6 months, which may not be sufficient to assess the long-term effectiveness of the treatment. The study did not compare the outcomes of intravesical onabotulinumtoxinA with other treatments.

    Experience with Intravesical Botox in Meningomyelocele-Related Bladder Dysfunction-A Single-Center Experience · 2026 · DOI

  • In conclusion, the distribution of IB cases worldwide does not reflect the detection of Clostridium botulinum spores in soil, suggesting IB is underrecognized in certain countries.

    Global Occurrence of Infant Botulism: 2007–2021 · 2025 · DOI

  • Most available studies are observational, involve relatively small patient cohorts, and rely predominantly on surrogate physiological endpoints rather than clinically meaningful outcomes - Significant intravascular volume shifts related to CPB priming, haemodilution, bleeding, transfusion, and volume replacement may also dynamically alter plasma drug concentrations - A substantial proportion of cardiac surgical…

    Nociception monitoring during cardiac surgery with cardiopulmonary bypass: limitations and future directions · 2026 · DOI

  • Future development may benefit from integration of multimodal physiological signals and machine learning-based approaches using large-scale physiological datasets - Cardiac surgery-specific validation of nociception monitoring technologies across different phases of surgery…

    Nociception monitoring during cardiac surgery with cardiopulmonary bypass: limitations and future directions · 2026 · DOI

Most-cited papers in Botulinum Toxin and Related Neurological Disorders

Most recent work

Find a gap in your own Botulinum Toxin and Related Neurological Disorders sub-topic

This page shows what the Botulinum Toxin and Related Neurological Disorders literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,304 open questions
Substance Abuse Treatment and Outcomes
1,956 open questions
Dementia and Cognitive Impairment Research
1,232 open questions
Ferroptosis and cancer prognosis
1,146 open questions
Liver Disease Diagnosis and Treatment
1,049 open questions
Smoking Behavior and Cessation
1,025 open questions
Physical Activity and Health
1,002 open questions
Attention Deficit Hyperactivity Disorder
982 open questions
Open questions raised by papers listed on this page include: (1) There is a lack of understanding of the role of higher-level cognitive and attentional processes in shaping motor control in dystonia (“Attentional or Non-Tactile Sensory Tricks in Idiopathic Cervical Dystonia: A…”, 2026); (2) There is a need to understand how toxin-receptor binding and other factors determine clinical effect (“Neuromodulators for Facial Aesthetics: Mechanistic Postulates and Clinical…”, 2026); (3) There is a need for further research on the long-term effects of botulinum toxin treatment (“The role of botulinum toxin in the treatment of patients in strabology and…”, 2026); (4) There is a lack of knowledge regarding the long-term outcomes of repeated cosmetic botulinum toxin injections (“АDVERSE EFFECTS AND NEUROLOGICAL DISORDERS AFTER INVASIVE COSMETOLOGY”, 2026); (5) Despite extensive research, the underlying aetiology remains unknown in a significant percentage of patients (primary or idiopathic tinnitus) (“Masseter Muscle in Somatosensory Tinnitus and Potential Therapeutic Role for…”, 2026). 98 gap statements have been mined from Botulinum Toxin and Related Neurological Disorders papers in our 4.5M-paper local library, which holds 713 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.